about
Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICADysbiosis in inflammatory bowel diseaseHow NOD2 mutations predispose to Crohn's disease?Ustekinumab as Induction and Maintenance Therapy for Crohn’s DiseaseSaccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis.Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon.Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils.Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR features.Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac diseaseCrohn's disease: beyond antagonists of tumour necrosis factor.Colonic inflammation in mice is improved by cigarette smoke through iNKT cells recruitment.PPAR-gamma in ulcerative colitis: a novel target for intervention.Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases.Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria.Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's diseaseSuperantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cellsProbiotics in inflammatory bowel disease: a critical review.Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease.Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease.Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier.Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn diseaseLRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease.Gut: An underestimated target organ for Aluminum.5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis.Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gammaGW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferationNovel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis.Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine.Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse.The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.Obesity, visceral fat and Crohn's disease.Visceral fat and gut inflammation.
P50
Q24292262-C88337B8-366B-444C-8BB8-4E182A17506BQ24685931-C63A4394-4FE2-45C6-8AE9-79C2C670E2AFQ28294389-7370C872-4CED-40B7-A5A6-FDDBDABC615DQ30054715-8B5DD96C-22D8-4E1A-A0D6-132039BD406AQ33469703-C2EFC045-CFE5-4AB8-A529-38C91F68F74DQ33928640-F00BA97A-E6C8-4ED1-AE12-A4045F50BD88Q33949335-06F5FC13-4592-488D-BBDB-21AB38622F24Q34408465-80647D5A-9F60-4697-A84C-9D18A8AE65D1Q34485066-5A628A28-A51A-4AAA-84DA-09FBF4E48EBCQ34502788-97E87B31-FDDB-43BB-B2C2-10D43986076CQ34575833-4906F4AC-CC59-4908-AC48-EAE30A567680Q34593801-BEF98904-51AC-48F5-8CC6-408E1EEA33C2Q34701073-BCA932EF-25F3-4FA2-A142-70480C9C43DBQ34708741-1CF160AC-C633-4441-8BFC-1A901DF37AFCQ34992771-87193524-448C-47B5-A78F-62355E7DEF1EQ35140083-4AD8E0FA-AEBD-4F3D-9B6C-E74FAEDBD9C6Q35364265-12209E71-F657-4CC1-8E80-6EC555849AB8Q35439554-07E1216C-C3C3-4022-ACCA-AD6288651878Q35542636-A399F95C-533C-4544-B31E-779D3589EB5AQ35593129-C2A2E830-5DE8-441D-A4FD-21322D9BB6C4Q35594252-6ACA4B47-1825-45E6-A490-C7D4AD3D4E95Q35605834-0EF1E280-CCFA-41C9-97EF-DD5188E5C25DQ35760524-1AEAA022-7C79-4F67-9C74-4D750C042549Q35794054-DD805EFA-0703-4DA3-B262-FEBE154C57BEQ35928929-79838D0F-1F71-415F-9615-155B35A531A1Q35955142-F601A0EC-B6D8-46F4-BD4A-B77B80C1AFA1Q36002369-29022BFE-AFAA-4DE6-8B78-73ADE96D233FQ36014007-B3D5F648-141C-481B-A49A-BCD4C638CE5AQ36282521-369BFAE8-01A9-45FE-938D-46A6D19C6F04Q36365651-5948F471-A23E-4C32-824E-BB5F1047D8A6Q36403491-C42A0763-C5B9-4E3F-943D-AF5A0F8D4815Q36459792-45A0D33F-68B8-4510-BA39-5A4368946626Q36479876-4BB8E80A-03C6-4207-B894-A343BA25F298Q36503299-07B0C45D-C338-42CE-9B66-94CA535B827AQ36587155-C3B33E09-91B3-48D5-87F4-2FC556685C80Q36758644-37C1A656-9BFF-4A48-9419-7E30BEA666BCQ37116354-26AC9339-E16A-414E-A3A8-535827390110Q37262181-39577DBE-AA97-4AC7-B2AA-5712E802A740Q37772038-8E2E6236-95BE-41DE-9EDB-ADE369EB491BQ37972334-9348EA9B-CF2E-41ED-8AB1-ED00C55DD793
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pierre Desreumaux
@ast
Pierre Desreumaux
@en
Pierre Desreumaux
@es
Pierre Desreumaux
@nl
type
label
Pierre Desreumaux
@ast
Pierre Desreumaux
@en
Pierre Desreumaux
@es
Pierre Desreumaux
@nl
prefLabel
Pierre Desreumaux
@ast
Pierre Desreumaux
@en
Pierre Desreumaux
@es
Pierre Desreumaux
@nl
P106
P21
P31
P496
0000-0002-6127-5281